Literature DB >> 27202264

Clinical and Economic Analysis of Effectiveness of Everolimus in the Treatment Of HR+, HER2- Advanced Breast Cancer in Russia.

L Krasnova1, P Vorobiev1, M Holownia1.   

Abstract

Entities:  

Year:  2014        PMID： 27202264     DOI： 10.1016/j.jval.2014.08.2280

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  1 in total

1.  Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2- Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study.

Authors:  Nanxin Li; Yanni Hao; Jipan Xie; Peggy L Lin; Valerie Koo; Erika Ohashi; Eric Q Wu
Journal:  Int J Breast Cancer       Date:  2015-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.